Promoting haemostasis for central venous access devices: a randomised controlled trial

Not Applicable

Recruiting

• Conditions: Central venous access device - associated bleeding; Central Venous Access Device - infection; Public Health - Health service research; Central Venous Access Device - dressing failure

• Registration Number: ACTRN12624000366550
• Lead Sponsor: niversity of Wollongong

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-03-28
• Last Update Posted: 29 July 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

Patient is
1. 18 years or older
2. Expected to require a CVAD for 48 hours or more
3. Currently an admitted patient or expected to be admitted to the hospital within 24 hours

Exclusion Criteria

Patient has
1. Burned or scarred skin at the CVAD insertion site
2. A known allergy to Chlorhexidine, potassium ferrate, or transparent dressing adhesives
3. Been commenced on end-of-life pathway
4. Previously enrolled in this study

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The requirement for the initial central venous access device (CVAD) dressing to be replaced due to evidence of bleeding, blood staining and/or soiling or loose/lifting edges before the scheduled dressing change on day 7 post-CVAD insertion. <br><br>Requirements for the initial dressing to be changed prior to 7 days will be determined by clinical staff. <br><br>This information will be collected by the research nurse from either direct observation; discussion with the participant or clinician who changed the dressing; or on review of paper or electronic medical records. [ Assessed daily from CVAD insertion up to any day prior to Day 7 post-CVAD insertion. <br>]